- The report features OncoMed Pharmaceuticals , Inc .' s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons To Buy - Evaluate OncoMed Pharmaceuticals , Inc .' s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information , analysis , and insights to formulate effective R & D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for OncoMed Pharmaceuticals , Inc . - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding OncoMed Pharmaceuticals , Inc .' s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Buy a Sample copy of This Report @ http :// www . radiantinsights . com / research / oncomed-pharmaceuticals-incproduct-pipeline-review-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 OncoMed Pharmaceuticals , Inc . Snapshot 6 OncoMed Pharmaceuticals , Inc . Overview 6 Key Information 6 Key Facts 6 OncoMed Pharmaceuticals , Inc . - Research and Development Overview 7 Key Therapeutic Areas 7 OncoMed Pharmaceuticals , Inc . - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products / Combination Treatment Modalities 13 OncoMed Pharmaceuticals , Inc . - Pipeline Products Glance 14 OncoMed Pharmaceuticals , Inc . - Clinical Stage Pipeline Products 14 Phase II Products / Combination Treatment Modalities 14 Phase I Products / Combination Treatment Modalities 15 OncoMed Pharmaceuticals , Inc . - Early Stage Pipeline Products 16 Preclinical Products / Combination Treatment Modalities 16 OncoMed Pharmaceuticals , Inc . - Drug Profiles 17 demcizumab 17 Product Description 17 Mechanism of Action 17 R & D Progress 17 tarextumab 21 Product Description 21 Mechanism of Action 21 R & D Progress 21 brontictuzumab 23 Product Description 23